4

$PFE · Pfizer Inc.

October 1, 2026 · AI-analyzed SEC filing · Verify material figures against the official SEC.gov filing

Pfizer Inc. filed a Form 4 with the SEC reporting a change in beneficial ownership for Albert Bourla, the company’s Chairman and CEO. The filing covers a transaction dated September 30, 2026, and was submitted on October 1, 2026.

According to the filing, Bourla acquired 21 phantom stock units under the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan. Each unit represents one phantom share of Pfizer common stock. These units are settled in cash following his separation from service and may be transferred into an alternative investment account at any time. The reported price for the units was $28.52 per unit.

Following the reported transaction, Bourla beneficially owned 783,888 phantom stock units. The filing does not report any acquisition or disposal of actual Pfizer common stock, only the phantom units under the deferred compensation plan.

Get filings like this before the market reacts.

Real-time SEC filing alerts, AI summaries, and a free daily digest — plus portfolio tracking that ties filings to your positions.

Start your free trial →